Merck & Co said on Friday updated data from its study of its experimental COVID-19 pill showed the drug was significantly less effective in cutting hospitalizations and deaths than previously reported.
Wow. Look at the result, HCQ group has 20% less hospitalization,
37% less pneamonia, and others. and this is "not" significant.
I thought they were saying if vaxx children can save one elder is worth it.
BTW, this study did not use other medications like Zinc, VC, etc.
:
: